Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Myrna R. Nahas"'
Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance
Publikováno v:
Case Reports in Dermatological Medicine, Vol 2020 (2020)
Background. Cutis laxa is a rare dermatosis that is inherited or acquired and clinically features loose, wrinkled, and redundant skin with decreased elasticity. This heterogeneous connective tissue disorder may be localized or generalized, with or wi
Externí odkaz:
https://doaj.org/article/8fbf98959e0e464db47374d6990e9a47
Autor:
Dina Stroopinsky, Anita G. Koshy, Jessica Liegel, Myrna R. Nahas, Giulia Cheloni, Joshua Hauser, Daniela Torres, Poorva Bindal, Maryam Rahimian, Lina Bisharat, Seo Yeon Yoo, Paula Fraenkel, Ozlem Yildirim, Helene Bonnevaux, Stephane Guerif, Donald Kufe, Jacalyn Rosenblatt, David Avigan
Publikováno v:
Transplantation and Cellular Therapy. 28:S216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::262eca3c9a295f14d9f76674adc72d02
https://doi.org/10.1016/s2666-6367(22)00430-4
https://doi.org/10.1016/s2666-6367(22)00430-4
Autor:
Myrna R. Nahas, Robert J. Soiffer, Edwin P. Alyea, Jon Arnason, Robin Joyce, Joseph H. Antin, Vincent T. Ho, Dina Stroopinsky, James D. Levine, Malgorzata McMasters, Salvia Jain, Ayad Hamdan, Mary Paty Bryant, Emma Logan, Josie Bazemore, Jeremy Stewart, Amy Joyce, Susan Stephenson, Abigail J. Washington, Leandra Cole, Athalia Rachel Pyzer, Rebecca Karp Leaf, David E. Avigan, Jacalyn Rosenblatt
Publikováno v:
Blood. 128:387-387
Introduction: Chronic graft versus host disease (cGVHD) remains a major source of morbidity and mortality following allogeneic transplantation. While corticosteroids remain first line therapy for cGVHD, they are associated with significant toxicity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2046a9757e9f4178d13cd83eb7d941f7
https://doi.org/10.1182/blood.v128.22.387.387
https://doi.org/10.1182/blood.v128.22.387.387
Autor:
Shalhout, Sophia Z.1 (AUTHOR), Nahas, Myrna R.2 (AUTHOR), Drews, Reed E.2 (AUTHOR), Miller, David M.1 (AUTHOR)
Publikováno v:
Case Reports in Dermatological Medicine. 2/23/2020, p1-10. 10p.
Autor:
Danwen Yang, Agrawal, Nikhil, Marcus, Chelsea, Roy, Neil, Richards, Katelyn R., Nahas, Myrna R., Cardarelli, Francesca
Publikováno v:
American Journal of Therapeutics; Jul/Aug2021, Vol. 28 Issue 4, pe488-e491, 4p
Autor:
Nahas, Myrna R., Stroopinsky, Dina, Rosenblatt, Jacalyn, Cole, Leandra, Pyzer, Athalia R., Anastasiadou, Eleni, Sergeeva, Anna, Ephraim, Adam, Washington, Abigail, Orr, Shira, McMasters, Malgorzata, Weinstock, Matthew, Jain, Salvia, Leaf, Rebecca K., Ghiasuddin, Haider, Rahimian, Maryam, Liegel, Jessica, Molldrem, Jeffrey J., Slack, Frank, Kufe, Donald
Publikováno v:
British Journal of Haematology; May2019, Vol. 185 Issue 4, p679-690, 12p, 1 Diagram, 5 Graphs
Autor:
Nahas MR, Arnason JE
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 43-53 (2015)
Myrna R Nahas, Jon E ArnasonBeth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is standardly managed with chemotherapy in combination with the anti-CD20 antibody ritu
Externí odkaz:
https://doaj.org/article/5553e19ee40f47e3a977ac5250db6693
Autor:
Bar ‐ Natan, Michal, Stroopinsky, Dina, Luptakova, Katarina, Coll, Maxwell D., Apel, Arie, Rajabi, Hasan, Pyzer, Athalia R., Palmer, Kristen, Reagan, Michaela R., Nahas, Myrna R., Karp Leaf, Rebecca, Jain, Salvia, Arnason, Jon, Ghobrial, Irene M., Anderson, Kenneth C., Kufe, Donald, Rosenblatt, Jacalyn, Avigan, David
Publikováno v:
British Journal of Haematology; Mar2017, Vol. 176 Issue 6, p929-938, 10p
Autor:
Arnason, Jon, Nahas,Myrna
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy.
Myrna R Nahas, Jon E ArnasonBeth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is standardly managed with chemotherapy in combination with the anti-CD20 antibody ritu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::04c9ab1d4a63fe69efdd203affead122
https://www.dovepress.com/targeting-cd20-in-chronic-lymphocytic-leukemia-peer-reviewed-article-BLCTT
https://www.dovepress.com/targeting-cd20-in-chronic-lymphocytic-leukemia-peer-reviewed-article-BLCTT